=+SA 8-6 Observe internal controls over cash Group Project OccuLogix, Inc., provides treatments for eye diseases, including age-related macular degeneration (AMD). The company’s treatment system, called the RHEO system, consists of an Octonova pump and disposable treatment sets that improve microcirculation in the eye by filtering high molecular weight proteins and other macromolecules from the patient’s plasma. OccuLogix reported the following data (in thousands) for the years ending December 31, 2006, 2005, 2004, and 2003: